On Posted on December 20, 2019January 8, 2020 by Megan Kuksuk to News OM1’s real-world evidence analytics banks $50M Series C News OM1’s real-world evidence analytics banks $50M Series C From MobiHealthNews by Dave Muoio 7Wire Venture’s portfolio company OM1, an artificial intelligence platform for clinical real-world evidence, announced the raise of $50 million Series C funding led by Scale Venture Partners, consisting of support from prior backers General Catalyst, Polaris Partners and 7wire Ventures. Search for: Search Recent Posts A New Look While Doubling Down on the Same Mission: 7wire Ventures Launches Refreshed Brand and Logo 7wire Ventures Presents: Top of the Ladder Featuring Override Health CEO Kili Preitauer 7wire 2025 Predictions Bridging the Rural-Urban Divide: Cultivating Digital Health Innovation in America’s Heartland 7wireVentures Presents: Top of the Ladder Featuring GroundGame.Health Co-Founder and CEO Susan Rawlings Molina Archives2024DecemberNovemberSeptemberAugustAprilMarchFebruary2023DecemberOctoberSeptemberJuneAprilMarchFebruary2022DecemberNovemberOctoberSeptemberJulyJuneAprilMarchFebruaryJanuary2021DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2020DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2019DecemberNovemberOctoberSeptemberJulyJuneMayAprilMarchFebruaryJanuary2018DecemberOctoberSeptemberAugustJulyJuneMayAprilMarchJanuary2017NovemberJulyJuneMarch2016DecemberOctoberAugustJulyAprilFebruary2015May2014DecemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2013DecemberNovemberOctoberSeptember Post Views: 1,992 Tags7wireInvestmentsOM1 PreviousPrevious post:10 top VCs share their best 2020 healthcare predictions, from a booming IPO market to pharma companies getting into the medical care business NextNext post:The Digital Health Landscape In 2020 And Beyond
News OM1’s real-world evidence analytics banks $50M Series C From MobiHealthNews by Dave Muoio 7Wire Venture’s portfolio company OM1, an artificial intelligence platform for clinical real-world evidence, announced the raise of $50 million Series C funding led by Scale Venture Partners, consisting of support from prior backers General Catalyst, Polaris Partners and 7wire Ventures. Search for: Search Recent Posts A New Look While Doubling Down on the Same Mission: 7wire Ventures Launches Refreshed Brand and Logo 7wire Ventures Presents: Top of the Ladder Featuring Override Health CEO Kili Preitauer 7wire 2025 Predictions Bridging the Rural-Urban Divide: Cultivating Digital Health Innovation in America’s Heartland 7wireVentures Presents: Top of the Ladder Featuring GroundGame.Health Co-Founder and CEO Susan Rawlings Molina Archives2024DecemberNovemberSeptemberAugustAprilMarchFebruary2023DecemberOctoberSeptemberJuneAprilMarchFebruary2022DecemberNovemberOctoberSeptemberJulyJuneAprilMarchFebruaryJanuary2021DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2020DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2019DecemberNovemberOctoberSeptemberJulyJuneMayAprilMarchFebruaryJanuary2018DecemberOctoberSeptemberAugustJulyJuneMayAprilMarchJanuary2017NovemberJulyJuneMarch2016DecemberOctoberAugustJulyAprilFebruary2015May2014DecemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2013DecemberNovemberOctoberSeptember Post Views: 1,992